Piedmont Investment Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-148,212
| Closed | -$4.84M | – | 96 |
|
|
2020
Q1 | $4.84M | Buy |
148,212
+18,139
| +14% | +$592K | 0.19% | 121 |
|
|
2019
Q4 | $5.88M | Buy |
130,073
+5,902
| +5% | +$267K | 0.2% | 114 |
|
|
2019
Q3 | $5.05M | Buy |
124,171
+1,754
| +1% | +$71.4K | 0.2% | 120 |
|
|
2019
Q2 | $5.26M | Buy |
122,417
+23,142
| +23% | +$995K | 0.21% | 118 |
|
|
2019
Q1 | $3.81M | Buy |
99,275
+2,045
| +2% | +$78.5K | 0.15% | 146 |
|
|
2018
Q4 | $3.44M | Buy |
97,230
+6,483
| +7% | +$229K | 0.16% | 134 |
|
|
2018
Q3 | $3.49M | Buy |
90,747
+31,275
| +53% | +$1.2M | 0.15% | 142 |
|
|
2018
Q2 | $1.95M | Sell |
59,472
-145,821
| -71% | -$4.77M | 0.09% | 221 |
|
|
2018
Q1 | $5.61M | Sell |
205,293
-88,938
| -30% | -$2.43M | 0.15% | 172 |
|
|
2017
Q4 | $7.29M | Sell |
294,231
-969
| -0.3% | -$24K | 0.15% | 179 |
|
|
2017
Q3 | $8.61M | Buy |
295,200
+2,726
| +0.9% | +$79.5K | 0.18% | 149 |
|
|
2017
Q2 | $8.11M | Buy |
292,474
+6,495
| +2% | +$180K | 0.18% | 149 |
|
|
2017
Q1 | $7.11M | Buy |
285,979
+2,466
| +0.9% | +$61.3K | 0.15% | 175 |
|
|
2016
Q4 | $6.13M | Buy |
283,513
+6,140
| +2% | +$133K | 0.13% | 184 |
|
|
2016
Q3 | $6.6M | Sell |
277,373
-28,665
| -9% | -$682K | 0.14% | 165 |
|
|
2016
Q2 | $7.15M | Buy |
+306,038
| New | +$7.15M | 0.15% | 160 |
|
|
2013
Q3 | – | Sell |
-239,800
| Closed | -$2.22M | – | 324 |
|
|
2013
Q2 | $2.22M | Buy |
+239,800
| New | +$2.22M | 0.1% | 124 |
|